Effect of pentagastrin on cholecystokinin and secretin choleresis in the dog.
D000818:Animals; D001639:Bicarbonates / Q000378:metabolism; D001646:Bile / Q000378:metabolism*; D002766:Cholecystokinin / Q000008:administration & dosage / Q000494:pharmacology*; D003864:Depression, Chemical; D004285:Dogs; D004386:Duodenum / Q000601:surgery; D005402:Fistula; D005750:Gastric Juice / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007275:Injections, Intravenous; D007419:Intestinal Secretions; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D010418:Pentagastrin / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D012633:Secretin / Q000008:administration & dosage / Q000494:pharmacology*; D012965:Sodium Chloride / Q000008:administration & dosage; D013268:Stimulation, Chemical; D013270:Stomach / Q000187:drug effects / Q000601:surgery; D013656:Taurocholic Acid / Q000008:administration & dosage; D013997:Time Factors
D001639:Bicarbonates; D012633:Secretin; D012965:Sodium Chloride; D013656:Taurocholic Acid; D002766:Cholecystokinin; D010418:Pentagastrin